Aan is positive on the Day and Week charts. It is crossing the MCAD and has room to run back to the upside to the premarked prices. It put in a double bottom on March 23-29. Let's see where it goes.
Insider ownership is above 8% and they are advertising regularly on prime time to get eyes on their living room, washable furniture that charges your phone. Image that in your living room. This is undervalued and has an $51 price target over the next year. They have been beating their earnings. The price is headed to the 200 EMA. It crossed the 50 EMA in January...
MACD crossover, oversold RSI at 33, Strat Squeeze underway, 121 uptrend, touching the 9 EMA, if pokes through it will go to the 20 EMA, Red on D,Q; Green on 4H,W,M
ADT is in an uptrend since July 2022 and is set to touch the 200 EMA. Earnings are coming up on Feb. 28, 2023. The forecast value is set for $10.20 and as high as $13.65. It is currently in a short downtrend but, still has room to improve.
Bullish trend on ESRT to $8.18, $8.22, $8.33 where each are in a resistance area. This is a bullish continuation of 122 on the daily. It has been bullish for DWMQ based from STRAT. Earnings are on Feb. 15th. Historically, it has risen based on earnings from the past 3 earnings however that is not always the future. My mental stop loss idea is in red at $7.45....
Looks like SPY is getting a bullish continuation formation with the 222 trend and a bullish DWMQ. I see the squeeze to the uptrend is setting up. I look for different targets in blue. Let's see how it works depending upon news, etc.
CEO has been buying shares since November 2022 - December 2022 setting up for 8.4% of insider ownership. Masimo has a market cap or net worth of $7.78 billion. The enterprise value is $8.52 billion.The stock price has decreased by -49.94% in the last 52 weeks. The beta is 0.88, so Masimo's price volatility has been lower than the market average. In the last 12...
I'm adding a new stock to my watchlist. $BCDA has Market Cap of 36.28 M and an Enterprise Value of 31.32 M. It has 31.3% insider ownership with the management buying shares each month since September 2022 through December 2022. They create cellular therapeutics for cardiovascular diseases. Their revenue has been growing 11% per year over the past 5 years. Price...
This is a company that has high insider ownership at 30% and more cash than debt with market cap at 255.22 M and enterprise value at 222.40 M. Balance Sheet The company has $166.31 million in cash and $133.49 million in debt, giving a net cash position of $32.82 million or $0.19 per share. The company has a current ratio of 3.20, with a Debt / Equity ratio of...
Many of the leaders bought this stock on December 20, 2022 for a total of 2,202,928 shares at about $1.75 each. The MACD has sellers cooling and buyers taking interest. We are in a bullish reversal with the STRAT and the targets are in blue. Exit is in red. This would also be a possible long term hold stock. Market Cap is 16.99 M and Enterprise value is ~2M with...
$DSNG had Director 10% - George Simeon buy 900,000 shares on Dec. 20, 2022 and Rodney Lappe, DIR bought 112,024 shares on December 9, 2022. This tells me they are bullish about their company. I also see the MACD sellers cooling and some nice volume coming in. Many are at the $8.06 level and the $16 level. I will wait for the MACD to cross for an entry. But the...
$SLB has been consolidating since October 25, 2022 in this channel. MACD is about to turn over and sellers are cooling off. The volume is showing that a potential for a move will be ready to run soon. Profit targets are labeled in blue with entry and exit points.
MACD is cooling off for the sellers and the STRAT is showing a 212 bullish reversal with a 66% win rate. Many are trapped in $85 area. In the blue are the targets based upon prior support and resistance levels. It will take its time but will make it back to $85.39.
I see a gap to fill from the high of $50 range back to the $27 range.
When I see a the CEO buying large amounts of the company in which they are managing I get to looking into the company. When I look at the technicals for this company. My checklist gets checked, some volume coming in, MACD crossover, EMA 8 closing the EMA 21 and RSI is under the 50. I see a 312 reversal with a gap to be filled, enterprise value is more than market...
DIBS has been consolidating since May 2022 with positive earnings. There is a MACD crossover setting up with low RSI and a Strat Bullish reversal in place. We could be setting up to make higher highs in the coming months back to the $8 range. Let's see how it does.
$PCT missed earnings and took a fall but, I see a MACD crossover forming, a low RSI, and volume sentiment coming back to this stock. I see analyst have it ranked at the highest of $30. So a nice long trade here should be profitable.
When looking at the history of bitcoin, I see a level of support at the ~$16K line. It reached this place in 2017, 2020, and 2022. The current trend is bearish but, if it holds which there is no indication technically speaking other than previous support zones then we could see a consolidation phase.